Unique Structural Features of the Peptidoglycan of Mycobacterium leprae
Year: 2007
Type: article
Abstract: The peptidoglycan structure of Mycobacterium spp. has been investigated primarily with the readily cultivable Mycobacterium smegmatis and Mycobacterium tuberculosis and has been shown to contain unusual features, including the occurrence of N-glycolylated, in addition to N-acetylated, muramic acid residues and direct cross-linkage between meso-diaminopimelic acid residues. Based on results from earlier studies, peptidoglycan from in vivo-derived noncultivable Mycobacterium leprae was assumed to possess the basic structural features of peptidoglycans from other mycobacteria, other than the reported replacement of l-alanine by glycine in the peptide side chains. In the present study, we have analyzed the structure of M. leprae peptidoglycan in detail by combined liquid chromatography and mass spectrometry. In contrast to earlier reports, and to the peptidoglycans in M. tuberculosis and M. smegmatis, the muramic acid residues of M. leprae peptidoglycan are exclusively N acetylated. The un-cross-linked peptide side chains of M. leprae consist of tetra- and tripeptides, some of which contain additional glycine residues. Based on these findings and genome comparisons, it can be concluded that the massive genome decay in M. leprae does not markedly affect the peptidoglycan biosynthesis pathway, with the exception of the nonfunctional namH gene responsible for N-glycolylmuramic acid biosynthesis.
Source: Journal of Bacteriology
DOI: 10.1128/jb.00982-07
Institution: Colorado State University
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: Menaquinone biosynthesis: a drug target in Gram-positive bacteria, G1998719991, G2573550422, G4958976895, Menaquinone Biosynthesis: A Drug Target in Gram-Positive Bacteria, Cell Wall Biogenesis-Target for new Anti-TB drugs, MYCOBACTERIAL CELL WALL AND DRUG DISCOVERY, Leprosy/Armadillo Support and Maintenance, MYOCOBACTERIAL CELL WALL AND DRUG DISCOVERY
OpenAlex ID: W2047907368
